Lubricin/proteoglycan 4 binding to CD44 receptor: A mechanism of the suppression of proinflammatory cytokine-induced synoviocyte proliferation by lubricin

Arthritis and Rheumatology

Volumn 67, Issue 6, 2015, Pages 1503-1513

  Al Sharif, Afnan ^a   Jamal, Maha ^a   Zhang, Ling X ^b   Larson, Katherine ^c   Schmidt, Tannin A ^d   Jay, Gregory D ^b,c   Elsaid, Khaled A ^a  

^a MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

^c BROWN UNIVERSITY   (United States)

^d UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMITOTIC AGENT; CD44V ANTIGEN; CYTOKINE; GLYCOSIDASE; HYALURONIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G1; INTERLEUKIN 1BETA; NEUTRALIZING ANTIBODY; O GLYCOSIDASE; RECOMBINANT HUMAN PROTEOGLYCAN 4; RECOMBINANT PROTEIN; SIALIDASE; SIALIDASE A; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VITRONECTIN; CD44 PROTEIN, HUMAN; CD44 PROTEIN, MOUSE; HERMES ANTIGEN; PRG4 PROTEIN, HUMAN; PRG4 PROTEIN, MOUSE; PROTEOGLYCAN;

ANIMAL CELL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; ARTHROPATHY; ARTICLE; CELL PROLIFERATION; CLINICAL EVALUATION; DRUG RECEPTOR BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; GLYCOSYLATION; MALE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SURFACE PLASMON RESONANCE; SYNOVIOCYTE; SYNOVIUM; ANIMAL; CYTOLOGY; DRUG EFFECTS; FIBROBLAST; GENETICS; HUMAN; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY;

ANIMALS; ANTIGENS, CD44; ARTHRITIS, RHEUMATOID; CELL PROLIFERATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLASTS; HUMANS; HYALURONIC ACID; INTERLEUKIN-1BETA; MICE; MICE, KNOCKOUT; PROTEOGLYCANS; SURFACE PLASMON RESONANCE; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84929898916     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39087     Document Type: Article

References (49)

1. Flannery CR, Hughes CE, Schumacher BL, Tudor D, Aydelotte MB, Kuettner KE, et al., Articular cartilage superficial zone protein (SZP) is homologous to megakaryocyte stimulating factor precursor and is a multifunctional proteoglycan with potential growth-promoting, cytoprotective, and lubricating properties in cartilage metabolism. Biochem Biophys Res Commun 1999; 254: 535-41.
2. Jay GD, Britt DE, Cha CJ., Lubricin is a product of megakaryocyte stimulating factor gene expression by human synovial fibroblasts. J Rheumatol 2000; 26: 2454-7.
3. Schmidt TA, Schumacher BL, Klein TJ, Voegtline MS, Sah RL., Synthesis of proteoglycan 4 by chondrocyte subpopulations in cartilage explants, monolayer cultures, and resurfaced cartilage cultures. Arthritis Rheum 2004; 50: 2849-57.
4. Zappone B, Ruths M, Greene GW, Jay GD, Israelachvili JN., Adsorption, lubrication, and wear of lubricin on model surfaces: polymer brush-like behavior of a glycoprotein. Biophys J 2007; 92: 1693-708.
5. Jay GD, Harris DA, Cha CJ., Boundary lubrication by lubricin is mediated by O-linked β(1-3)Gal-GalNAc oligosaccharides. Glycoconj J 2001; 18: 807-15.
6. Gleghorn JP, Jones AR, Flannery CR, Bonassar LJ., Boundary mode lubrication of articular cartilage by recombinant human lubricin. J Orthop Res 2009; 27: 771-7.
7. Schmidt TA, Gastelum NS, Nguyen QT, Schumacher BL, Sah RL., Boundary lubrication of articular cartilage: role of synovial fluid constituents. Arthritis Rheum 2007; 56: 882-91.
8. Rhee DK, Marcelino J, Baker M, Gong Y, Smits P, Lefebvre V, et al., The secreted glycoprotein lubricin protects cartilage surfaces and inhibits synovial cell overgrowth. J Clin Invest 2005; 115: 622-31.
9. Flannery CR, Zollner R, Corcoran C, Jones AR, Root A, Rivera- Bermudez MA, et al., Prevention of cartilage degeneration in a rat model of osteoarthritis by intraarticular treatment with recombinant lubricin. Arthritis Rheum 2009; 60: 840-7.
10. Jay GD, Fleming BC, Watkins BA, McHugh KA, Anderson SC, Zhang LX, et al., Prevention of cartilage degeneration and restoration of chondroprotection by lubricin tribosupplementation in the rat following anterior cruciate ligament transection. Arthritis Rheum 2010; 62: 2382-91.
11. Teeple E, Elsaid KA, Jay GD, Zhang L, Badger GJ, Akelman M, et al., Effects of supplemental intra-articular lubricin and hyaluronic acid on the progression of posttraumatic arthritis in the anterior cruciate ligament-deficient rat knee. Am J Sports Med 2011; 39: 164-72.
12. Jay GD, Elsaid KA, Kelly KA, Anderson SC, Zhang L, Teeple E, et al., Prevention of cartilage degeneration and gait asymmetry by lubricin tribosupplementation in the rat following anterior cruciate ligament transection. Arthritis Rheum 2012; 64: 1162-71.
13. Elsaid KA, Zhang L, Waller K, Tofte J, Teeple E, Fleming BC, et al., The impact of forced joint exercise on lubricin biosynthesis from articular cartilage following ACL transection and intra-articular lubricin's effect in exercised joints following ACL transection. Osteoarthritis Cartilage 2012; 20: 940-8.
14. Jay GD, Torres JR, Warman ML, Laderer MC, Breuer KS., The role of lubricin in the mechanical behavior of synovial fluid. Proc Natl Acad Sci U S A 2007; 104: 6194-9.
15. Kwiecinski JJ, Dorosz SG, Ludwig TE, Abubacker S, Crowman MK, Schmidt TA., The effect of molecular weight on hyaluronan's cartilage boundary lubricating ability-alone and in combination with proteoglycan 4. Osteoarthritis Cartilage 2011; 19: 1356-62.
16. Das S, Banguy X, Zappone B, Greene GW, Jay GD, Israelachvili JN., Synergistic interactions between grafted hyaluronic acid and lubricin provides enhanced wear protection and lubrication. Biomacromolecules 2013; 14: 1669-77.
17. Taguchi M, Zhao C, Sun YL, Jay GD, An KN, Amadio PC., The effect of surface treatment using hyaluronic acid and lubricin on the gliding resistance of human extrasynovial tendons in vitro. J Hand Surg Am 2009; 34: 1276-81.
18. Underhill C., CD44: the hyaluronan receptor. J Cell Sci 1992; 103: 293-8.
19. Pure E, Cuff C., A crucial role for CD44 in inflammation. Trends Mol Med 2001; 7: 213-21.
20. Suenaga N, Mori H, Itoh Y, Seiki M., CD44 binding through hemopexin-like domain is critical for its shedding by membrane-type 1 matrix metalloproteinase. Oncogene 2005; 24: 859-68.
21. Samson ML, Morrison S, Masala N, Sullivan BD, Sullivan DA, Sheardown H, et al., Characterization of full-length recombinant human proteoglycan 4 as an ocular surface boundary lubricant. Exp Eye Res 2014; 127: 14-9.
22. Zheng Z, Katoh S, He Q, Oritani K, Miyake K, Lesley J, et al., Monoclonal antibodies to CD44 and their influence on hyaluronan recognition. J Cell Biol 1995; 130: 485-95.
23. Cutly M, Nguyen HA, Underhill CB., The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J Cell Biol 1992; 116: 1055-62.
24. Knudson W, Chow G, Knudson CB., CD44-mediated uptake and degradation of hyaluronan. Matrix Biol 2002; 21: 15-23.
25. Harada H, Takashashi M., CD44-dependent intracellular and extracellular catabolism of hyaluronic acid by hyaluronidase-1 and-2. J Biol Chem 2007; 282: 5597-607.
26. Tibesku CO, Szuwart T, Ocken SA, Skwara A, Fuchs S., Expression of the matrix receptor CD44v5 on chondrocytes changes with osteoarthritis: an experimental investigation in the rabbit. Ann Rheum Dis 2006; 65: 105-8.
27. Fuchs S, Dankbar B, Wildenau G, Goetz W, Lohmann CH, Tibesku CO., Expression of the CD44 variant isoform 5 in the human osteoarthritic knee joint: correlation with radiological, histomorphological, and biochemical parameters. J Orthop Res 2004; 22: 774-80.
28. Zhang FJ, Luo W, Gao SG, Su DZ, Li YS, Zeng C, et al., Expression of CD44 in articular cartilage is associated with disease severity in knee osteoarthritis. Mod Rheumatol 2013; 23: 1186-91.
29. Naor D, Sionov RV, Ish-Shalom D., CD44: structure, function and association with the malignant process. Adv Cancer Res 1997; 71: 241-319.
30. Knudson W, Loeser RF., CD44 and integrin matrix receptors participate in cartilage homeostasis. Cell Mol Life Sci 2002; 59: 36-44.
31. Julovi SM, Yasuda T, Shimizu M, Hiramitsu T, Nakamura T., Inhibition of interleukin-1β-stimulated production of matrix metalloproteinases by hyaluronan via CD44 in human articular cartilage. Arthritis Rheum 2004; 50: 516-25.
32. Julovi SM, Ito H, Nishanti K, Jackson CJ, Nakamura T., Hyaluronan inhibits matrix metalloproteinase-13 in human arthritic chondrocytes via CD44 and P38. J Orthop Res 2011; 29: 258-64.
33. Yatabe T, Mochizuki S, Takizawa M, Chijiwa M, Okada A, Kimura T, et al., Hyaluronan inhibits expression of ADAMTS4 (aggrecanases-1) in human osteoarthritic chondrocytes. Ann Rheum Dis 2009; 68: 1051-8.
34. Yasuda T., Hyaluronan inhibits p38 mitogen-activated protein kinase via the receptors in rheumatoid arthritis chondrocytes stimulated with fibronectin fragment. Clin Rheumatol 2010; 29: 1259-67.
35. Kataoka Y, Ariyoshi W, Okinaga T, Kaneuji T, Mitsugi S, Takahashi T, et al., Mechanisms involved in suppression of ADAMTS4 expression in synoviocytes by high molecular weight hyaluronic acid. Biochem Biophys Res Commun 2013; 432: 580-5.
36. Waddell DD, Kolomytkin OV, Dunn S, Marino AA., Hyaluronan suppresses IL-1β-induced metalloproteinase activity from synovial tissue. Clin Orthop Relat Res 2007; 465: 241-8.
37. Wang CT, Lin YT, Chiang BL, Lin YH, Hou SM., High molecular weight hyaluronic acid down-regulated the gene expression of osteoarthritis-associated cytokines and enzymes in fibroblast-like synoviocytes from patients with early osteoarthritis. Osteoarthritis Cartilage 2006; 14: 1237-47.
38. Hiraoki N, Takahashi KA, Arai Y, Sakao K, Mazda O, Kishida T, et al., Intra-articular injection of hyaluronan restores the aberrant expression of matrix metalloproteinase-13 in osteoarthritic subchondral bone. J Orthop Res 2011; 29: 354-60.
39. Ariyoshi W, Okinaga T, Knudson CB, Knudson W, Nishihara T., High molecular weight hyaluronic acid regulates osteoclast formation by inhibiting receptor activator of NF-κB ligand through Rho kinase. Osteoarthritis Cartilage 2014; 22: 111-20.
40. Estrella RP, Whitelock JM, Packer NH, Karlesson NG., The glycosylation of human synovial lubricin: implication for its role in inflammation. Biochem J 2010; 429: 359-67.
41. Jin C, Ekwall AK, Bylund J, Bjorkman L, Estrella RP, Whitelock JM, et al., Human synovial lubricin expresses sialyl Lewis x determinant and has L-selectin ligand activity. J Biol Chem 2012; 287: 35922-33.
42. Naor D, Nedvetzki S., CD44 in rheumatoid arthritis. Arthritis Res Ther 2003; 5: 105-15.
43. Grisar J, Munk M, Steiner CW, Amoyo-Minar L, Tohidast-Akrad M, Zenz P, et al., Expression patterns of CD44 and CD44 splice variants in patients with rheumatoid arthritis. Clin Exp Rheumatol 2012; 30: 64-72.
44. Wibulswas A, Croft D, Bacarese-Hamilton I, McIntyre P, Genot E, Kramer IM., The CD44v7/8 epitope as a target to restrain proliferation of fibroblast-like synoviocytes in rheumatoid arthritis. Am J Pathol 2000; 157: 2037-44.
45. Runnels HA, Weber GL, Min J, Kudlacz EM, Zobel JF, Donovan CB, et al., PF-03475952: a potent and neutralizing fully human anti-CD44 antibody for therapeutic applications in inflammatory diseases. Adv Ther 2010; 27: 168-80.
46. Lacey D, Sampey A, Mitchell R, Bucala R, Santos L, Leech M, et al., Control of fibroblast-like synoviocyte proliferation by macrophage migration inhibitory factor. Arthritis Rheum 2003; 48: 103-9.
47. Jay GD, Torres JR, Rhee DK, Helminen HJ, Hytinnen MM, Cha CJ, et al., Association between friction and wear in diarthrodial joints lacking lubricin. Arthritis Rheum 2007; 56: 3662-9.
48. Waller KA, Zhang LX, Elsaid KA, Fleming BC, Warman ML, Jay GD., Role of lubricin and boundary lubrication in the prevention of chondrocyte apoptosis. Proc Natl Acad Sci U S A 2013; 110: 5852-7.
49. Jay GD, Waller KA., The biology of lubricin: near frictionless joint motion. Matrix Biol 2014; 39: 17-24.